Equity (Tables)

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Schedule of stock option activity

	Number of Options (in Shares)		Weighted Average Exercise Price
Outstanding, December 31, 2022		1,607,500	$	2.00
Granted		-	$	-
Exercised		-		-
Forfeited or cancelled		-		-
Outstanding, March 31, 2023		1,607,500	$	2.00
Exercisable, March 31, 2023		1,607,500	$	2.00

Share-Based Payment Arrangement, Activity [Table Text Block]

	Number of Warrants (in Shares)		Weighted Average Exercise Price
Outstanding, December 31, 2022		1,010,084,263	$	.001	*
Granted		-		-
Exercised		-		-
Outstanding, March 31, 2023		1,010,084,263	$	.001

* The exercise price will be determined by a 5-day VWAP price calculation on the exercise date.

	Prefunded Warrants
Outstanding, December 31, 2022		3,000,000
New issuances		-
Exercised		-
Outstanding, March 31, 2023		3,000,000

Schedule of share derivative liabilities

	March 31,		December 31,
	2023		2022
Warrants	$	436	$	272
Stock options		1		1
Total share derivative liability	$	437	$	273

Schedule of reverse stock split balance sheet

			Proforma
	As Stated		Effect
Balance Sheet
Common stock:
Shares Issued:
3/31/2023		2,484,501,880		2,484,502
12/31/2022		2,484,501,880		2,484,502
Shares Outstanding:
3/31/2023		2,484,426,501		2,484,427
12/31/2022		2,484,426,501		2,484,427
Treasury Stock:		75,379		75

Schedule of reverse stock split EPS

		Three Months Ended March 31,
EPS		2023			2022
Weighted Average Shares
Outstanding – basic and diluted	As stated		2,487,426,501			174,980,542
	Proforma		2,487,427			174,981
Net income (loss) per share:
Continuing operations	As stated		(0.0004	)		(0.021	)
	Proforma		(0.40	)		(21.0	)
Discontinued Operations	As stated		(0.0003	)		0.004
	Proforma		(0.30	)		4.0